Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin.
Authors:
- R F HunterRHR F Hunter
- N G MoldNMN G Mold
- R B MitchellRMR B Mitchell
- A T HuangAHA T Huang
- 1 July 1985
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (14) , 4823-4827
Abstract
Antithymocyte globulin (ATG) therapy is an important treatment alternative for patients with acquired plastic anemia. The mechanism by which it exerts it effects on hematopoiesis is unknown. The ability of horse ATG to induce growth and differentiation of normal bone marrow is described. A single cell suspension of normal human bone marrow was cultured in methylcellulose medium and examined for the growth and maturation after incubation with ATG (10 .mu.g/ml). After 3-4 days of culture, spherical colonies containing mature myeloid elements were found in cultures containing ATG but not in cultures containing medium or preimmunization horse IgG. The addition of 10% colony-stimulating factor increased growth by 40%. The number of spherical colonies is not dependent on the presence of macrophages or T lymphocytes. This property of ATG may be relevant to the mechanism behind the hematologic recovery in some patients with acquired aplastic anemia. The ability of ATG to induce terminal differentiation in the HL60 leukemic cell line is described. ATG binds to HL60 cells and at concentrations between 10 and 100 .mu.g/ml, 50% of the cells become mature granulocytes, acquire the ability to reduce nitroblue tetrazolium, and lose their proliferative capacity in the clonogenic assay. These new observations of ATG-induced differentiation of normal marrow myeloid elements and terminal differentiation of the HL60 cell line point to different avenues for future search of differentiation-inducing agents.Keywords
This publication has 14 references indexed in Scilit:
- Circulating Activated Suppressor T Lymphocytes in Aplastic AnemiaNew England Journal of Medicine, 1985
- Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.BMJ, 1981
- THERAPY OF ACUTE CADAVERIC RENAL ALLOGRAFT REJECTION WITH ADJUNCTIVE ANTITHYMOCYTE GLOBULINTransplantation, 1980
- Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.Proceedings of the National Academy of Sciences, 1980
- USE OF ATG IN TREATMENT OF STEROID-RESISTANT REJECTIONTransplantation, 1980
- INFLUENCE OF CULTURE CONDITIONS ON THE PRODUCTION OF COLONY-STIMULATING ACTIVITY BY HUMAN-PLACENTA1980
- MANUFACTURE OF ANTITHYMOCYTE GLOBULIN (ATGAM) FOR CLINICAL TRIALSTransplantation, 1979
- Induction of Differentiation in Human Promyelocytic Leukemia Cells by Tumor PromotersScience, 1979
- Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.Journal of Experimental Medicine, 1979
- Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte GlobulinBlood, 1974